Project 1: Human epidemiology in the context of the VL elimination initiative Project Summary Project 1 ?Human epidemiology in the context of the VL elimination initiative? seeks to provide essential epidemiological evidence in the context of the VL elimination initiative in Bihar State, India. The project combines epidemiological field work with laboratory work, all study designs are observational. There are 4 specific aims in the project, the first is to consolidate the TMRC-supported KAMRC as a center of excellence for surveillance and monitoring of L.donovani transmission and VL incidence. We plan to continue the registration of new VL cases and vital events that occur in the study population we have enrolled in the Health and Demographical Surveillance Site (HDSS) in Muzaffarpur district. In a subset of this HDSS population we will conduct a repeat sero-survey to allow us to compare the current prevalence of L. donovani infection with that in the 2007 survey, conducted in the early years of the VL elimination initiative.
Other aims of Project 1 are (1) to use global metabolomic profiling to understand the role of asymptomatic individuals in transmission (cross reference to Project 2) and progression to disease, especially those that fall into different classes according to parasite load in the blood and/or ability to make antigen-specific antibody versus T cell responses, (2) to study co-infections with other neglected tropical diseases (NTDs) as a determinant for progression to VL, and opening up to a wider scope for understanding NTDs in the project area, and (3) to use gut metagenomics to determine the contribution of the gut microbiome, and the broader burden of gut pathogens, as risk factors for progression to clinical VL. The project is linked to transmission studies described in Project 2 andimmunological work described in Project 3, and is firmly rooted in the research infrastructure provided by the HDSS described as Scientific Core, which we have been gradually developing over the past ten years.

Public Health Relevance

Project 1: Human epidemiology in the context of the VL elimination initiative Project Narrative This Project will provide population-based evidence on the ten-year trend in L. donovani and VL incidence in Bihar State, and hence allow for impact evaluation of an important public health program in India. Metabolomic profiling of asymptomatic carriers will guide development of biomarkers for (i) progression to clinical VL, and (ii) transmissibility. The gut microbiome study will help us to understand the influence of co-infections with gut pathogens on the clinical outcome of infection with L. donovani.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI074321-13
Application #
9690542
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
13
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Banaras Hindu University
Department
Type
DUNS #
650330558
City
Varanasi
State
Country
India
Zip Code
221005
Sundar, Shyam; Singh, Om Prakash (2018) Molecular Diagnosis of Visceral Leishmaniasis. Mol Diagn Ther :
Sundar, Shyam; Singh, Bhawana (2018) Emerging therapeutic targets for treatment of leishmaniasis. Expert Opin Ther Targets 22:467-486
Sundar, Shyam; Singh, Bhawana (2018) Understanding Leishmania parasites through proteomics and implications for the clinic. Expert Rev Proteomics 15:371-390
Sundar, Shyam; Agarwal, Dipti (2018) Visceral Leishmaniasis-Optimum Treatment Options in Children. Pediatr Infect Dis J 37:492-494
Singh, Neetu; Sundar, Shyam (2018) Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. PLoS One 13:e0199817
Singh, Neetu; Kumar, Rajiv; Chauhan, Shashi Bhushan et al. (2018) Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis. J Infect Dis 218:1130-1141
Hasker, Epco; Malaviya, Paritosh; Cloots, Kristien et al. (2018) Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis. Am J Trop Med Hyg 99:1555-1561
Singh, Toolika; Fakiola, Michaela; Oommen, Joyce et al. (2018) Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis. J Immunol 200:2727-2737
Kansal, S; Chakravarty, J; Kumar, A et al. (2017) Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India. Trop Med Int Health 22:1037-1042
Singh, Neetu; Sundar, Shyam (2017) Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells. Mol Immunol 85:111-119